Skip to main content

Table 1 Study Population

From: Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus

  Total Men Women
Type 1 Diabetes mellitus 19 (32%) 11 (35%) 8 (29%)
Type 2 Diabetes mellitus 40 (68%) 20 (65%) 20 (71%)
Age 63.3 ± 1.7 63.5 ± 2.4 63 ± 2.6
Diabetes duration 20.7 ± 1.4 20.4 ± 2.1 21 ± 1.7
Hypertension 51 (86%) 27 (87%) 22 (79%)
Systolic blood pressure 135 ± 2 133 ± 3 137 ± 3
Diastolic blood pressure 77 ± 1 76 ± 2 77 ± 2
Hyperlipoproteinemia 39 (66%) 19 (61%) 20 (71%)
Smoker 4 (7%) 3 (10%) 1 (4%)
BMI (kg/m 2 ) 27.8 ± 0.6 27.3 ± 0.6 28.3 ± 1.2
Coronary heart disease 22 (37%) 15 (48%) 7 (25%)
Cerebrovascular disease 11 (19%) 8 (26%) 3 (11%)
Peripheral artery disease 15 (25%) 10 (32%) 5 (18%)
Insulintherapy 51 (86%) 25 (81%) 26 (93%)
Oral antidiabetic drugs 21 (36%) 11 (35%) 10 (36%)
ACEI/ARB 43 (73%) 23 (74%) 20 (71%)
Lipid lowering drugs 36 (61%) 19 (61%) 17 (61%)
HbA1c (%) 7.3 ± 0.1 7.5 ± 0.2 7.1 ± 1.3
Creatinine (mg/dl) 1.2 ± 0.2 1.3 ± 0.2 1.1 ± 0.2*
LDL-Cholesterol (mg/dl) 101.9 ± 3.7 102.4 ± 5.1 101.3 ± 5.6
HDL-Cholesterol (mg/dl) 49.9 ± 1.9 47.2 ± 2.6 52.6 ± 2.8
Triglycerides (mg/dl) 181.0 ± 16.5 168.3 ± 18.3 195.1 ± 29.0
  1. Parameters without a unit in brackets indicate number of patients (and percentages).
  2. Parameters with a unit in brackets are mean ± SEM
  3. ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blocker
  4. LDL, low density lipoprotein; HDL, high density lipoprotein
  5. * p < 0.05 vs. men